Duality Biotherapeutics, Inc. (9606) Income Statement

Last quarter (Q2 2025), Duality Biotherapeutics, Inc.'s total revenue was ¥614.47M, an increase of 455.46% from the same quarter last year. In Q2, Duality Biotherapeutics, Inc.'s net income was ¥-1.04B. See Duality Biotherapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.